title: Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial.
abstract: BACKGROUND
  Correction of anemia in type 2 diabetes (T2DM) patients with chronic kidney disease stages 3-4 may slow the decline of kidney function but may increase cardiovascular risk through higher hematocrit. The NEPHRODIAB2 study was designed to assess efficacy and safety of complete hemoglobin (Hb) normalization in these patients.
  
  
  METHODS
  We randomly assigned 89 T2DM patients with an estimated glomerular filtration rate (eGFR; abbreviated 175 Modification of Diet in Renal Disease formula) of 25 to 60 ml/min per 1.73 m(2) and moderate anemia (Hb, 100-129 g/l) to a target Hb value in subnormal range (110-129g/l, group 1, n=43) or normal range (130-149 g/l, group 2, n=46). The primary end point was eGFR decline after 2 years of follow-up. Secondary end points included iron and erythropoietin dosage, quality of life (Medical Outcomes Study 36-item Short-Form Health Survey scores) and adverse events.
  
  
  RESULTS
  Six months after randomization, the mean Hb levels were <120 g/l in group 1 and >130 g/l in group 2 (P<.05 at 6, 12, 18 and 24 months). Blood pressure, 24-h proteinuria and HbA1c did not differ during follow-up (P>.05). Two-year declines in eGFR were -8.7±12.2 in group 1 and -5.1±7.8 ml/min per 1.73 m(2) in group 2 (P=.29). Mean weekly use of erythropoietin was 7.8±11.6 μg in group 1 and 30.1±33.6 μg in group 2 (P<.0001). There was no significant difference regarding Medical Outcomes Study 36-item Short-Form Health Survey score change or adverse event occurrence.
  
  
  CONCLUSIONS
  In this trial, normalization of Hb level in T2DM patients with chronic kidney disease was safe but did not significantly slow renal function decline and increased treatment cost due to erythropoietin use.
authors: Hospices Civils de Lyon, Department of Nephrology, Lyon Sud Hospital, Pierre Benite, France. emmanuel.villar@chu-lyon.fr
authors: Emmanuel
authors: E
authors: Villar
authors: Michel
authors: M
authors: Lièvre
authors: Michèle
authors: M
authors: Kessler
authors: Vincent
authors: V
authors: Lemaître
authors: Eric
authors: E
authors: Alamartine
authors: Michel
authors: M
authors: Rodier
authors: Maud
authors: M
authors: François
authors: Philippe
authors: P
authors: Zaoui
authors: Olivier
authors: O
authors: Moranne
authors: Gabriel
authors: G
authors: Choukroun
authors: Abdallah
authors: A
authors: Guerraoui
authors: Anne
authors: A
authors: Jolivot
authors: Gérard
authors: G
authors: Janin
authors: Bernard
authors: B
authors: Branger
authors: Anne-Elisabeth
authors: AE
authors: Heng
authors: Catherine
authors: C
authors: Boudray
authors: Alvine
authors: A
authors: Bissery
authors: Muriel
authors: M
authors: Rabilloud
authors: Claire
authors: C
authors: Pouteil-Noble